N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments, gene therapy and vaccines, is pleased to provide an update on its
N4 Pharma PLC (AIM:N4P) AAV Viral Vector Update
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments, gene therapy and vaccines, is pleased to provide a further successful update
Traders Cafe with Zak Mir: Bulletin Board Heroes, Friday 5th January 2024
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Gold, ANGLE, Bluebird,
Share Talk Weekly Small Cap Movers & Shakers, Saturday 23rd December 2023
The FTSE AIM-All-Share Index joined in the holiday cheer, rising by 170 basis points to end the week just over the 751 mark. The junior market slightly outperformed the FTSE
N4 Pharma PLC (AIM:N4P) Oral Delivery Update
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to provide a positive update on its ongoing
Traders Cafe with Zak Mir: Bulletin Board Heroes, Wednesday 13th December 2023
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Audioboom, AFC, Anglesey,
N4 Pharma PLC (AIM:N4P) Nuvec® R&D and Strategy Update
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to provide an encouraging update on its ongoing in
Traders Cafe with Zak Mir: Bulletin Board Heroes, Wednesday 20th September 202
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Corcel, Capital Metals, Great
N4 Pharma PLC (AIM:N4P) Patent Grant and Board Change
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, announces two operational updates.
Traders Cafe with Zak Mir: Bulletin Board Heroes, Tuesday 25th April 2023
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, African Pioneer, Arc, Biome,
N4 Pharma PLC (AIM:N4P) siRNA update
N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system for cancer treatments and vaccines, is pleased to provide a further update on its ongoing
N4 Pharma’s share price has risen due to positive developments related to Nuvec
N4 Pharma PLC’s (AIM: N4P) shares have risen by more than 7% following the biotech firm’s announcement that it has successfully completed the single loading of EGFR and BCL-2 siRNA